• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-abl在费城染色体阳性急性髓性白血病中的表达。

Expression of c-abl in Philadelphia-positive acute myelogenous leukemia.

作者信息

Kurzrock R, Shtalrid M, Talpaz M, Kloetzer W S, Gutterman J U

机构信息

Department of Clinical Immunology, M.D. Anderson Hospital and Tumor Institute at Houston, TX 77030.

出版信息

Blood. 1987 Nov;70(5):1584-8.

PMID:3311207
Abstract

The identical cytogenetic marker, t(9;22)(q34;q11) (Philadelphia [Ph] translocation), is found in approximately 90%, 20%, and 2% of adult patients with chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myelogenous leukemia (AML), respectively. In CML, the molecular events resulting from the Ph translocation include a break within the bcr locus on chromosome 22, transfer of the c-abl protooncogene from chromosome 9 to 22, and formation of an aberrant 210-kD bcr-abl fusion protein (p210bcr-abl). Recently, the absence of bcr rearrangement and expression of a distinct aberrant 190-kd abl protein (p190c-abl) has been described in Ph-positive ALL, with the suggestion that the two abl variants may be pathogenetically associated with myeloid v lymphoid leukemogenesis. Here we report that the genomic configuration and translation product of Ph-positive AML can be similar to that of Ph-positive ALL: the break at 22q11 may occur outside the 5.8 kb bcr region and result in expression of a 190-kD abl protein lacking these bcr sequences. Phosphokinase enzymatic activity, a fundamental property of p210bcr-abl, was also associated with AML-derived p190c-abl. Our current observations indicate that p190c-abl can be found in cells of lymphoid or myeloid lineage and is therefore unlikely to play a specific role in the development of lymphoid leukemias. Formation of p190c-abl instead of p210bcr-abl appears to be a characteristic of the acute rather than the chronic Ph-positive leukemic state.

摘要

相同的细胞遗传学标记,即t(9;22)(q34;q11)(费城[Ph]易位),分别在约90%的成年慢性髓性白血病(CML)患者、20%的急性淋巴细胞白血病(ALL)患者和2%的急性髓性白血病(AML)患者中被发现。在CML中,Ph易位导致的分子事件包括22号染色体上bcr基因座内的断裂、c-abl原癌基因从9号染色体转移至22号染色体,以及形成异常的210-kD bcr-abl融合蛋白(p210bcr-abl)。最近,在Ph阳性ALL中已发现不存在bcr重排且表达一种独特的异常190-kd abl蛋白(p190c-abl),这表明这两种abl变体可能在发病机制上与髓系和淋巴系白血病发生相关。在此我们报告,Ph阳性AML的基因组结构和翻译产物可能与Ph阳性ALL相似:22q11处的断裂可能发生在5.8 kb bcr区域之外,并导致缺乏这些bcr序列的190-kD abl蛋白的表达。磷酸激酶酶活性是p210bcr-abl的一项基本特性,它也与AML来源的p190c-abl相关。我们目前的观察结果表明,p190c-abl可在淋巴系或髓系细胞谱系中发现,因此不太可能在淋巴系白血病的发生中发挥特定作用。形成p190c-abl而非p210bcr-abl似乎是急性而非慢性Ph阳性白血病状态的一个特征。

相似文献

1
Expression of c-abl in Philadelphia-positive acute myelogenous leukemia.c-abl在费城染色体阳性急性髓性白血病中的表达。
Blood. 1987 Nov;70(5):1584-8.
2
Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.费城染色体阳性急性淋巴细胞白血病中bcr和c-abl基因的独特融合
Cell. 1987 Oct 9;51(1):33-40. doi: 10.1016/0092-8674(87)90007-9.
3
Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course.无断点簇区域重排的费城染色体阴性慢性髓性白血病:一种具有独特临床病程的慢性髓系白血病。
Blood. 1990 Jan 15;75(2):445-52.
4
[Molecular genetics of the pathogenesis and classification of chronic myelocytic leukemia].[慢性粒细胞白血病发病机制与分类的分子遗传学]
Onkologie. 1987 Jun;10(3):127-32. doi: 10.1159/000216391.
5
Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.白血病细胞系:用于研究费城染色体阳性白血病的体外模型。
Leuk Res. 1999 Mar;23(3):207-15. doi: 10.1016/s0145-2126(98)00171-4.
6
The genomic breakpoint in a patient with Philadelphia-positive acute leukemia is 5' of the breakpoint cluster region.
Cancer Genet Cytogenet. 1988 Jun;32(2):217-27. doi: 10.1016/0165-4608(88)90284-1.
7
Rearrangement of the breakpoint cluster region and expression of P210 BCR-ABL in a "masked" Philadelphia chromosome-positive acute myeloid leukemia.
Blood. 1988 Nov;72(5):1829-32.
8
Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia.费城阴性慢性髓性白血病中断点簇集区的重排与临床病程
Ann Intern Med. 1986 Nov;105(5):673-9. doi: 10.7326/0003-4819-105-5-673.
9
Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemia.慢性粒细胞白血病中p210bcr-abl分子变异体的鉴定
Blood. 1987 Jul;70(1):233-6.
10
The molecular pathology of chronic myelogenous leukaemia.慢性粒细胞白血病的分子病理学
Br J Haematol. 1991 Oct;79 Suppl 1:34-7. doi: 10.1111/j.1365-2141.1991.tb08116.x.

引用本文的文献

1
If it is a solid tumor target, then it may be a hematologic cancer target: Bridging the great divide.如果它是实体瘤靶点,那么它可能是血液系统癌症靶点:弥合巨大差距。
Med. 2025 Jan 10;6(1):100550. doi: 10.1016/j.medj.2024.11.003. Epub 2024 Dec 16.
2
Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms.治疗性癌症疫苗——抗原发现与佐剂递送平台
Pharmaceutics. 2022 Jul 11;14(7):1448. doi: 10.3390/pharmaceutics14071448.
3
Anti-leukemic activity of axitinib against cells harboring the BCR-ABL T315I point mutation.
阿昔替尼对携带BCR-ABL T315I点突变细胞的抗白血病活性。
J Hematol Oncol. 2015 Aug 4;8:97. doi: 10.1186/s13045-015-0190-9.
4
[Clinical and laboratory characteristics of 12 Ph/BCR-ABL positive acute myeloid leukemia patients].12例Ph/BCR-ABL阳性急性髓系白血病患者的临床及实验室特征
Zhonghua Xue Ye Xue Za Zhi. 2015 May;36(5):398-402. doi: 10.3760/cma.j.issn.0253-2727.2015.05.010.
5
The treatment of adolescents and young adults with acute lymphoblastic leukemia.急性淋巴细胞白血病青少年和青年患者的治疗。
Curr Hematol Malig Rep. 2013 Jun;8(2):91-7. doi: 10.1007/s11899-013-0159-0.
6
Clinical applications of BCR-ABL molecular testing in acute leukemia.BCR-ABL分子检测在急性白血病中的临床应用
J Mol Diagn. 2003 May;5(2):63-72. doi: 10.1016/S1525-1578(10)60454-0.
7
Philadelphia chromosome-positive acute myeloid leukemia with tetraploidy.伴有四倍体的费城染色体阳性急性髓系白血病
Int J Hematol. 2002 Jan;75(1):63-6. doi: 10.1007/BF02981981.
8
The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.BCR/ABL癌基因的P190、P210和P230形式在小鼠中诱导出类似慢性髓性白血病的综合征,但具有不同的淋巴细胞白血病致瘤活性。
J Exp Med. 1999 May 3;189(9):1399-412. doi: 10.1084/jem.189.9.1399.
9
Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.Bcr、Abl和Bcr-Abl蛋白在正常细胞和白血病细胞中的亚细胞定位以及表达与髓系分化的相关性。
J Clin Invest. 1993 Oct;92(4):1925-39. doi: 10.1172/JCI116786.
10
Oncogenes: present status.
Indian J Pediatr. 1993 Mar-Apr;60(2):193-201. doi: 10.1007/BF02822176.